Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
1:03:23
Anticoagulation for AF, VTE and PVT in Cirrhosis
16:12
Transthyretin Amyloid and New Treatment Options
56:26
Navigating the 2024 PAD Guidelines
1:01:24
DOACs and Kidney Dysfunction
1:01:00
Discussion of 2023 AFib Guidelines
1:00:34
An Update on Breast Cancer Pathology Webinar Recording - 12-9-21
1:27:01